Fuse Vectors has raised $5.2 million of funding as it moves closer to commercialising its innovative new approach to ...

Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s ...

The funding will accelerate the development of Fuse's technology platform and pipeline of novel gene therapies. With its ...

Four children born with a rare genetic form of severe blindness have all experienced significant improvements in their ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...

OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic ...

Revolutionary gene therapy approaches show promise in treating various retinal conditions, potentially transforming treatment ...

A gene therapy from Regeneron Pharmaceuticals Inc. improved hearing in nearly all deaf children in a clinical trial, results ...

A Connecticut boy is among four children all born with severe childhood blindness who gained “life-changing improvements” to ...

An experimental trial of gene therapy has helped four toddlers - born with one of the most severe forms of childhood ...

YolTech's gene therapy is intended as a one-time life-long cure for patients living with PH1, which can lead to kidney ...